Sign in and upgrade to a paid plan to export financials as CSV.

Ajooni Biotech Limited

Fast Moving Consumer Goods

NSE: AJOONI
₹3.13
▼ -0.01 (-0.32%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
10/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-5.8
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹-24 Cr
as of March 31, 2026
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 2 met
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.3%
Low 3.1000 · High 3.1600
1W return
-4.6%
Low 3.1000 · High 3.3200
1M return
-18.5%
Low 3.0200 · High 3.8500
52W return
-40.5%
Low 3.0200 · High 5.5000
Lifetime High ₹81.8000 (Feb. 9, 2022)
Lifetime Low ₹3.1300 (Sept. 30, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
3.2
10D
3.2
20D
3.3
50D
3.6
100D
3.8
200D
4.1

Delivery and volume

Day avg. delivery
60.3%
Week avg. delivery
70.3%
Month avg. delivery
74.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

3.13
Pivot
First resistance3.16
Second resistance3.19
Third resistance3.22
First support3.10
Second support3.07
Third support3.04
Day RSI29.4
Day MFI28.9
Day MACD-0.16
Day MACD signal-0.15

Beta

1M0.78
3M0.70
1Y0.71
3Y0.83

Price change analysis

↓ -18.5%
Over 1 Month
LowHigh
3.023.85
↓ -16.1%
Over 3 Months
LowHigh
3.024.39
↓ -23.8%
Over 6 Months
LowHigh
3.024.50
↓ -40.5%
Over 1 Year
LowHigh
3.025.50
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹63 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹

Shareholding pattern / Ownership

Shareholding summary

Aug 2026
  • Promoter30.53%

Largest holders

NameCategoryShares %Shares
JASJOT SINGHPromoter15.9800%28968521
HEALTHY BIOSCIENCES LIMITEDPromoter4.9700%9000000
PARMJEET KAURPromoter4.3000%7790976
UPNEET KAURPromoter2.4200%4383540
ANANTHARAMAN JANAKIPublic1.8100%3277500

As of Aug. 12, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings increased from 26.89% to 30.53% in Aug 2026 qtr

Historical fii holding

Historical mutual fund holding

All shareholding details →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
31 Dec 2025 Healthy Biosciences Limited Promoter Sell 0 ₹0
31 Dec 2025 parmjeet Kaur Promoter group Buy 0 ₹0
31 Dec 2025 Jasjot Singh Promoter Buy 0 ₹0
24 Dec 2025 Healthy Biosciences Limited Promoter Sell 0 ₹0
24 Dec 2025 Jasjot Singh Promoter Buy 0 ₹0
24 Dec 2025 parmjeet Kaur Promoter group Buy 0 ₹0
30 Sep 2023 JASJOT SINGH Promoter Sell 0 ₹0
30 Sep 2023 ISHNEET KAUR Promoter group Sell 0 ₹0
30 Sep 2023 UPNEET KAUR Promoter group Sell 0 ₹0
21 Sep 2023 ISHNEET KAUR Promoter group Sell 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
7 Sep 2026 ANANTHARAMAN JANAKI Bulk Sell 1,073,331 3.5700 NSE
2 Jan 2025 NEO APEX VENTURE LLP Bulk Sell 1,050,000 8.5500 NSE
2 Jan 2025 NEO APEX VENTURE LLP Bulk Buy 650,000 8.5500 NSE
30 Aug 2024 SHUBHAM KUMAR Bulk Buy 864,087 8.9000 NSE
30 Aug 2024 SHUBHAM KUMAR Bulk Sell 864,087 8.9800 NSE
26 Jul 2024 GADARA POONAM Bulk Buy 900,400 7.0700 NSE
9 Jul 2024 PUNJAB BIOTECHNOLOGY PARK LIMITED Bulk Sell 1,200,000 6.9000 NSE
9 Jul 2024 JASPAL SINGH BINDRA Bulk Buy 1,395,090 7.1700 NSE
9 Jul 2024 GAYATRIBEN NISHANT SHAH Bulk Sell 1,106,586 6.9700 NSE
9 Jul 2024 GAYATRIBEN NISHANT SHAH Bulk Buy 1,106,586 6.9400 NSE

All bulk and block deals →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
14 Aug 2026 Financial Results Yes
29 Jun 2026 Fund Raising/Other business matters —
28 May 2026 Financial Results Yes
30 Jan 2026 Financial Results/Other business matters Yes
13 Nov 2025 Financial Results Yes

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

  • RSI in oversold territory (29.4) -- a technical rebound zone

Threats

  • Down 40.5% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Ajooni Biotech Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.